Sodium glucose co-transport-2 (SGLT-2) inhibitors, a new class of glucose-lowering agents, reduce tubular glucose reabsorption, producing a reduction of blood glucose without stimulating insulin release. The aim of the present meta-analysis is the assessment of the overall efficacy and safety profile of these drugs.
Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials / Monami, M; Nardini, C; Mannucci, E. - In: DIABETES, OBESITY AND METABOLISM. - ISSN 1462-8902. - STAMPA. - 16:(2014), pp. 457-466. [10.1111/dom.12244]
Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials
MANNUCCI, EDOARDO
2014
Abstract
Sodium glucose co-transport-2 (SGLT-2) inhibitors, a new class of glucose-lowering agents, reduce tubular glucose reabsorption, producing a reduction of blood glucose without stimulating insulin release. The aim of the present meta-analysis is the assessment of the overall efficacy and safety profile of these drugs.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Monami_et_al-2014-Diabetes,_Obesity_and_Metabolism (3).pdf
Accesso chiuso
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Tutti i diritti riservati
Dimensione
698.08 kB
Formato
Adobe PDF
|
698.08 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
